Clearside Biomedical, Inc. (CLSD) reported a quarterly loss of $1.14 per share, missing the Zacks Consensus Estimate of a loss of $0.67. This represents an earnings surprise of -70.15%. Revenues were $0.2 million, falling short of expectations by 23.57%. The stock has dropped 74.1% this year.

The company has surpassed consensus EPS estimates three times in the last four quarters. The future stock performance depends on management’s commentary and earnings outlook. Estimates for the coming quarter predict a loss of $0.67 per share and $0.26 million in revenues. The Zacks Rank for the stock is currently #4 (Sell).

Agilent Technologies (A) is set to report quarterly earnings on November 24. Expected earnings are $1.59 per share, up 8.9% year-over-year. Revenues are projected to be $1.83 billion. The stock remains a key player in the medical sector and is closely monitored for its performance.

Read more at Nasdaq: Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates